Suchergebnisse - "O3J8G9O825"

PubPharm (5.515)

131

Two-Drug Regimen Containing Darunavir : Metabolic Evaluation of an Old Dual Therapy

enthalten in: AIDS research and human retroviruses | 2023

von Farinacci, D. | Iannone, V. | D'Angelillo, A. | +4

132

Neurological side effects and drug interactions of antiviral compounds against SARS-CoV-2

enthalten in: European journal of neurology | 2023

von Akhvlediani, T. | Bernard-Valnet, R. | Dias, S. | +4

133

Evaluating variations in bilirubin glucuronidation activity by protease inhibitors in canine and human primary hepatocytes cultured in a 3D culture system

enthalten in: Toxicology in vitro : an international journal published in association with BIBRA | 2023

von Omori, H. | Chikamoto, J. | Nagahara, M. | +2

134

A first-in-human phase 1 study of simnotrelvir, a 3CL-like protease inhibitor for treatment of COVID-19, in healthy adult subjects

enthalten in: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences | 2023

von Yang, X. | Yang, Y. | Yao, B. | +26

135

SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy : An Observational Study

enthalten in: Annals of internal medicine | 2023

von Edelstein, G. | Boucau, J. | Uddin, R. | +19

UpdateOf: medRxiv. 2023 Jun 27;:. - PMID 37425934

136

Small-molecule anti-COVID-19 drugs and a focus on China's homegrown mindeudesivir (VV116)

enthalten in: Frontiers of medicine | 2023

von Cao, Q. | Ding, Y. | Xu, Y. | +8

137

Nirmatrelvir/ritonavir use in patients with COVID-19 on hemodialysis : a case series

enthalten in: Diagnostic microbiology and infectious disease | 2023

von Zhang, A. | Diao, Z. | Wang, G. | +6

138

Effectiveness of Nirmatrelvir-Ritonavir Against the Development of Post-COVID-19 Conditions Among U.S. Veterans : A Target Trial Emulation

enthalten in: Annals of internal medicine | 2023

von Ioannou, G. | Berry, K. | Rajeevan, N. | +16

139

Nirmatrelvir combined with ritonavir for preventing and treating COVID-19

enthalten in: The Cochrane database of systematic reviews | 2023

von Reis, S. | Metzendorf, M. | Kuehn, R. | +6

UpdateOf: Cochrane Database Syst Rev. 2022 Sep 20;9:CD015395. - PMID 36126225

140

Evaluation of the efficacy and safety of oral N-acetylcysteine in patients with COVID-19 receiving the routine antiviral and hydroxychloroquine protocol : A randomized controlled clinical trial

enthalten in: Immunity, inflammation and disease | 2023

von Atefi, N. | Goodarzi, A. | Riahi, T. | +7